Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2019 Nov 13;160(1):261–271.e1. doi: 10.1016/j.jtcvs.2019.10.102

FIGURE 2.

FIGURE 2.

Geographic representation of the percentage of patients receiving National Comprehensive Cancer Network (NCCN) guideline-concordant adjuvant therapy following surgery for pathologic N1 or N2 non-small cell lung cancer in the United States, by state.